SARS-CoV-2 Infections, Hospitalizations, and Mortality in Vaccinated Patients With Cancer in the US

Yung-Shuo Kao¹, James Cheng-Chung Wei^{2

3

4}, Chih-Jung Yeh⁵

Affiliations

¹ Department of Radiation Oncology, China Medical University Hospital, Taichung, Taiwan.
² Department of Allergy, Immunology & Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan.
³ Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
⁴ Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.
⁵ Department of Public Health, Chung Shan Medical University, Taichung, Taiwan.

Comment

Yung-Shuo Kao et al. JAMA Oncol. 2022.

. 2022 Oct 1;8(10):1514-1515.

doi: 10.1001/jamaoncol.2022.3045.

Yung-Shuo Kao¹, James Cheng-Chung Wei^{2

3

4}, Chih-Jung Yeh⁵

¹ Department of Radiation Oncology, China Medical University Hospital, Taichung, Taiwan.
² Department of Allergy, Immunology & Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan.
³ Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
⁴ Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.
⁵ Department of Public Health, Chung Shan Medical University, Taichung, Taiwan.

No abstract available

Comment in

SARS-CoV-2 Infections, Hospitalizations, and Mortality in Vaccinated Patients With Cancer in the US-Reply.
Xu R, Berger NA. Xu R, et al. JAMA Oncol. 2022 Oct 1;8(10):1516-1517. doi: 10.1001/jamaoncol.2022.3060. JAMA Oncol. 2022. PMID: 35925574 No abstract available.

Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Mortality in Vaccinated Patients With Cancer in the US Between December 2020 and November 2021.
Wang W, Kaelber DC, Xu R, Berger NA. Wang W, et al. JAMA Oncol. 2022 Jul 1;8(7):1027-1034. doi: 10.1001/jamaoncol.2022.1096. JAMA Oncol. 2022. PMID: 35394485 Free PMC article.